{"schema_version":"secwatch.filing_event.v1","accession":"0001606498-26-000061","form_type":"8-K","ticker":"AVNS","cik":"0001606498","company_name":"AVANOS MEDICAL, INC.","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.584401+00:00","generated_at":"2026-05-14T23:23:27.567249+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Avanos Medical announces Q1 2026 results; filing includes no financial figures","bullets":["Press release issued May 5, 2026 covering three months ended March 31, 2026.","No specific revenue, EPS, or segment data available in the filing excerpt.","Investors should refer to the full press release for detailed results."],"urls":{"canonical":"https://secwatch.observer/filing/0001606498-26-000061","json":"https://secwatch.observer/filing/0001606498-26-000061.json","markdown":"https://secwatch.observer/filing/0001606498-26-000061.md","text":"https://secwatch.observer/filing/0001606498-26-000061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/avns-20260505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:23:27.567249+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"295be4d8ae70b30b8c86ba7c744a7b161585d13f","claim":"AVANOS MEDICAL, INC. reported financial results for the three months ended March 31, 2026.","evidence_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001878848-26-000028","ticker":"IREN","company_name":"IREN Ltd","filed_at":"2026-05-11T23:59:59+00:00","headline":"IREN holds Q3 FY26 earnings call; transcript lacks financial specifics in filing","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001878848-26-000028","json":"https://secwatch.observer/filing/0001878848-26-000028.json","markdown":"https://secwatch.observer/filing/0001878848-26-000028.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1878848/000187884826000028/0001878848-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1878848/000187884826000028/iren-20260508.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","comparable_excerpt":"On May 7, 2026, IREN Limited (the “Company”) conducted a conference call to discuss its financial results for the three months ended March 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1878848/000187884826000028/0001878848-26-000028-index.htm"}},{"accession":"0001527541-26-000137","ticker":"WHLR","company_name":"Wheeler Real Estate Investment Trust, Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Wheeler REIT announces Q1 2026 results available on investor website; no specific figures provided in 8-K","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001527541-26-000137","json":"https://secwatch.observer/filing/0001527541-26-000137.json","markdown":"https://secwatch.observer/filing/0001527541-26-000137.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527541/000152754126000137/0001527541-26-000137-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527541/000152754126000137/whlr-20260508.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","comparable_excerpt":"On May 8, 2026, Wheeler Real Estate Investment Trust, Inc. (the “Company”) issued a press release announcing that it had reported its financial and operating results for the three months ended March 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1527541/000152754126000137/0001527541-26-000137-index.htm"}},{"accession":"0001901606-26-000015","ticker":null,"company_name":"Golub Capital Direct Lending Unlevered Corp","filed_at":"2026-05-08T23:59:59+00:00","headline":"Golub Capital Direct Lending Unlevered Q2 2026 earnings presentation filed; no financial figures in 8-K text","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001901606-26-000015","json":"https://secwatch.observer/filing/0001901606-26-000015.json","markdown":"https://secwatch.observer/filing/0001901606-26-000015.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1901606/000190160626000015/0001901606-26-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1901606/000190160626000015/gdlcu-20260508.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","comparable_excerpt":"On May 8, 2026 , in connection with the release of its financial results for its second fiscal quarter ended March 31, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1901606/000190160626000015/0001901606-26-000015-index.htm"}},{"accession":"0001326380-26-000020","ticker":"GME","company_name":"GameStop Corp.","filed_at":"2026-06-02T20:43:35+00:00","headline":"GameStop Q1 record net income $389.6M, revenue up 14%, new $2B buyback","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings"],"urls":{"canonical":"https://secwatch.observer/filing/0001326380-26-000020","json":"https://secwatch.observer/filing/0001326380-26-000020.json","markdown":"https://secwatch.observer/filing/0001326380-26-000020.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326380/000132638026000020/0001326380-26-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326380/000132638026000020/gme-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","comparable_excerpt":"Net sales were $835.3 million for the first quarter","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1326380/000132638026000020/0001326380-26-000020-index.htm"}},{"accession":"0001628280-26-039805","ticker":"GTLB","company_name":"Gitlab Inc.","filed_at":"2026-06-02T20:17:31+00:00","headline":"GitLab Q1 revenue $264M (+23% YoY); plans 14% workforce cut, $30-35M charges","event_type":"earnings","sec_items":["2.02","2.05","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039805","json":"https://secwatch.observer/filing/0001628280-26-039805.json","markdown":"https://secwatch.observer/filing/0001628280-26-039805.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653482/000162828026039805/0001628280-26-039805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653482/000162828026039805/gtlb-20260601.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","comparable_excerpt":"in such filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nGitLab Reports First Quarter Fiscal Year 2027 Financial Results First Quarter Fiscal Year 2027 Highlights: • Total revenue of $264.2 million, up 23% year-over-year • GAAP operating margin of (6)%; non-GAAP operating margin of 14% • Operating cash flow of $149.2 million and non-GAAP adjusted free cash flow of $146.7","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1653482/000162828026039805/0001628280-26-039805-index.htm"}},{"accession":"0001040130-26-000016","ticker":"PETS","company_name":"PETMED EXPRESS INC","filed_at":"2026-06-02T20:15:54+00:00","headline":"PetMed Q4 sales fall 15.6% to $42.8M; FY net loss widens to $57.3M on goodwill impairment","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings"],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-26-000016","json":"https://secwatch.observer/filing/0001040130-26-000016.json","markdown":"https://secwatch.observer/filing/0001040130-26-000016.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000016/0001040130-26-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000016/pets-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","comparable_excerpt":"Net sales of $179.0 million compared to $227.0 million in the prior year, a decrease of 21.1%, primarily driven by a decline in prescription medication sales. • Net loss of $57.3 million, or $(2.74) per diluted share, compared to a net loss of $6.3 million, or $(0.30) per diluted share in the prior year.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000016/0001040130-26-000016-index.htm"}},{"accession":"0001193125-26-253505","ticker":"SPWH","company_name":"SPORTSMAN'S WAREHOUSE HOLDINGS, INC.","filed_at":"2026-06-02T20:10:20+00:00","headline":"Sportsman's Warehouse Q1 net sales up 2.8% to $256.1M; same-store sales +2.1%; net loss $21.8M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253505","json":"https://secwatch.observer/filing/0001193125-26-253505.json","markdown":"https://secwatch.observer/filing/0001193125-26-253505.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1132105/000119312526253505/0001193125-26-253505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1132105/000119312526253505/spwh-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","comparable_excerpt":"and generating positive free cash flow to further strengthen our balance sheet through debt reduction.” For the thirteen weeks ended May 2, 2026: • Net sales increased 2.8% to $256.1 million, compared to $249.1 million in the first quarter of fiscal year 2025. Performance was driven primarily by a 7.4% gain in Hunting and Shooting Sports, led by firearms, ammunition,","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1132105/000119312526253505/0001193125-26-253505-index.htm"}},{"accession":"0001327567-26-000012","ticker":"PANW","company_name":"Palo Alto Networks Inc","filed_at":"2026-06-02T20:08:29+00:00","headline":"Palo Alto Networks Q3 revenue $3.0B (+31% YoY); NGS ARR $8.1B (+60% YoY)","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings"],"urls":{"canonical":"https://secwatch.observer/filing/0001327567-26-000012","json":"https://secwatch.observer/filing/0001327567-26-000012.json","markdown":"https://secwatch.observer/filing/0001327567-26-000012.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1327567/000132756726000012/0001327567-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1327567/000132756726000012/panw-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm","comparable_excerpt":"chief financial officer of Palo Alto Networks. Third Quarter Fiscal 2026 Financial Highlights • Total revenue for the fiscal third quarter 2026 grew 31% year over year to $3.0 billion. This includes $388 million from CyberArk and Chronosphere. • Next-Generation Security ARR for the fiscal third quarter 2026 grew 60% year over year to $8.1 billion. This","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1327567/000132756726000012/0001327567-26-000012-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}